LEADER 01615nam  2200469Ia 450 
001 9910696219403321
005 20071130162931.0
035   $a(CKB)5470000002376630
035   $a(OCoLC)182631466
035   $a(EXLCZ)995470000002376630
100   $a20071130d2001      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPeru investigation report$b[electronic resource] $ethe April 20, 2001 Peruvian shootdown accident
210  1$aWashington :$cBureau for International Narcotics and Law Enforcement Affairs,$d2001.
215   $a1 electronic text $cHTML file
300   $aTitle from title screen (viewed on Nov. 29, 2007)
300   $a"August 2, 2001."
320   $aIncludes bibliographical references.
517   $aPeru investigation report 
606   $aDrug traffic$zPeru
606   $aDrug control$zPeru
606   $aTechnical assistance, American$zPeru
606   $aFriendly fire (Military science)$zPeru
606   $aAir interdiction
606   $aAircraft accidents$xInvestigation$zPeru
615  0$aDrug traffic
615  0$aDrug control
615  0$aTechnical assistance, American
615  0$aFriendly fire (Military science)
615  0$aAir interdiction.
615  0$aAircraft accidents$xInvestigation
712 02$aUnited States.$bBureau for International Narcotics and Law Enforcement Affairs.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696219403321
996   $aPeru investigation report$93439843
997   $aUNINA

LEADER 02641nam  22005295  450 
001 9910155302903321
005 20200703134306.0
010   $a9783319483603
024 7 $a10.1007/978-3-319-48360-3
035   $a(CKB)3710000000964728
035   $a(DE-He213)978-3-319-48360-3
035   $a(MiAaPQ)EBC4748454
035   $a(PPN)197141420
035   $a(EXLCZ)993710000000964728
100   $a20161125d2017      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCancer Biomarkers in Body Fluids $eBiomarkers in Circulation /$fby Gabriel D. Dakubo
205   $a1st ed. 2017.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017.
215   $a1 online resource (XIX, 509 p. 20 illus. in color.) 
311   $a3-319-48359-5 
311   $a3-319-48360-9 
320   $aIncludes bibliographical references at the end of each chapters and index.
330   $aThis book examines in depth the evidence, clinical applications and potential cancer signatures in the circulation and discusses alterations in circulating cell-free nucleic acids, and circulating tumor DNA, as well as the epigenome, genome, transcriptome (coding and noncoding), proteome (both traditional serum proteins and proteomic profiles) and metabolome. Further, it highlights the clinical applications of circulating tumor cells for each cancer type and addresses the emerging importance of extracellular vesicular contents, including miRNA, oncogenes and drug resistant factors. As such, it offers a valuable reference guide for cancer researchers, oncologists, clinicians, surgeons, medical students, oncology nurses, diagnostic laboratories, and the pharmaceutical industry.
606   $aHuman genetics
606   $aOncology
606   $aCancer$xResearch
606   $aHuman Genetics$3https://scigraph.springernature.com/ontologies/product-market-codes/B12008
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
615  0$aHuman genetics.
615  0$aOncology.
615  0$aCancer$xResearch.
615 14$aHuman Genetics.
615 24$aOncology.
615 24$aCancer Research.
676   $a611.01816
676   $a599.935
700   $aDakubo$b Gabriel D$4aut$4http://id.loc.gov/vocabulary/relators/aut$0972626
906   $aBOOK
912   $a9910155302903321
996   $aCancer Biomarkers in Body Fluids$92212304
997   $aUNINA